Evolva raises CHF28 million as it gears up for Arpida merger
This article was originally published in Scrip
Executive Summary
Evolva, which recently entered a merger agreement with fellow Swiss biotech companyArpida (scripnews.com, September 10th, 2009), has raised CHF28 million ($28 million) in the first closing of a series B round.